|
|
|
|
 |
|
| Welcome to the Clinical Testing Solutions newsletter, April 2022. In this edition you'll find downloadable posters on COVID-19 testing solutions, a webinar and blog posts on the Omicron variant, and infographics on Pharmacogenomics and S gene target failure. Read the latest updates from Clinical Conversations, a new home for our blog posts, and stay up to date with the latest In Vitro Diagnostic Regulation (IVDR) news. |
|
|
|
|
|
|
|
Scientific posters: COVID-19 testing solutions
Download these free posters from recent scientific conferences to learn about our COVID‑19 testing solutions.
Download now »
|
|
|
|
|
 |
Responding to SARS‑CoV‑2 variants, such as Omicron: Detection and surveillance
Watch on demand » |
|
 |
As the SARS‑CoV‑2 virus evolves, PCR diagnostic and surveillance solutions help stay ahead of viral variants
Read blog » |
|
|
 |
Detecting Omicron's arrival with airport wastewater surveillance
Read blog » |
|
|
|
|
 |
Learn more about the impact of Pharmacogenomics
Download this free infographic to learn more about how Pharmacogenomics impacts us and our medication responses.
Download now » |
|
 |
Get the facts about S gene target failure
What does S gene target failure mean for your COVID‑19 tests? Download this free infographic to learn more about the Spike protein of SARS‑CoV‑2, the 60–70del mutation, and the S gene target failure.
Download now » |
|
|
|
|
|
|
|
SARS-CoV-2 mutations, their attributes, and conducting surveillance studies
Staying ahead of mutations may come down to a simple understanding of lineage and which viral family they belong to.
Read blog »
|
|
|
|
Analyses of COVID‑19 testing and surveillance technologies point to accurate, reliable solutions for pandemic control
A collection of technical posters from recent scientific meetings highlights key analyses validating COVID‑19 tests used within communities, and summarises studies of the surveillance technologies that empowered global monitoring and mitigation efforts in the face of mutations.
Read blog »
|
|
|
|
|
|
|
